ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-32E15216
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Research Report 2023
BUY CHAPTERS

Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Research Report 2025

Code: QYRE-Auto-32E15216
Report
June 2025
Pages:67
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
Beijing Minhai Biotechnology
Kangtai
Walvax Biotechnology
hualanbio

Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market

The global market for Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Acellular diphtheria pertussis Haemophilus influenzae type b combined vaccine is used to prevent various diseases caused by Bordetella pertussis, Diphtheria bacillus, Clostridium tetani and Haemophilus influenzae type b. Suitable for infants aged 3 months to 2 years old.
North American market for Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine include Sanofi, Beijing Minhai Biotechnology, Kangtai, Walvax Biotechnology, HualanBio, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine.
The Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Report

Report Metric Details
Report Name Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market
Segment by Type
  • 0.5mL Dose
  • 1.5mL Dose
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi, Beijing Minhai Biotechnology, Kangtai, Walvax Biotechnology, HualanBio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market report?

Ans: The main players in the Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market are Sanofi, Beijing Minhai Biotechnology, Kangtai, Walvax Biotechnology, HualanBio

What are the Application segmentation covered in the Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market report?

Ans: The Applications covered in the Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market report are Hospital, Clinic, CDC

What are the Type segmentation covered in the Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market report?

Ans: The Types covered in the Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market report are 0.5mL Dose, 1.5mL Dose

Recommended Reports

Pertussis-Diphtheria Vaccines

Influenza & Viral Vaccines

Child & Combination Vaccines

1 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Overview
1.1 Product Definition
1.2 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine by Type
1.2.1 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 0.5mL Dose
1.2.3 1.5mL Dose
1.3 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine by Application
1.3.1 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 CDC
1.4 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size Estimates and Forecasts
1.4.1 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue 2020-2031
1.4.2 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales 2020-2031
1.4.3 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Competition by Manufacturers
2.1 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine, Date of Enter into This Industry
2.8 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Competitive Situation and Trends
2.8.1 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Players Market Share by Revenue
2.8.3 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Scenario by Region
3.1 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales by Region: 2020-2031
3.2.1 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales by Region: 2020-2025
3.2.2 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales by Region: 2026-2031
3.3 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Region: 2020-2031
3.3.1 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Region: 2020-2025
3.3.2 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Region: 2026-2031
3.4 North America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Facts & Figures by Country
3.4.1 North America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales by Country (2020-2031)
3.4.3 North America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Facts & Figures by Country
3.5.1 Europe Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales by Country (2020-2031)
3.5.3 Europe Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Facts & Figures by Country
3.7.1 Latin America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales by Type (2020-2031)
4.1.1 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales by Type (2020-2025)
4.1.2 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales by Type (2026-2031)
4.1.3 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Type (2020-2031)
4.2.1 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Type (2020-2025)
4.2.2 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Type (2026-2031)
4.2.3 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales by Application (2020-2031)
5.1.1 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales by Application (2020-2025)
5.1.2 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales by Application (2026-2031)
5.1.3 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Application (2020-2031)
5.2.1 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Application (2020-2025)
5.2.2 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Application (2026-2031)
5.2.3 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Beijing Minhai Biotechnology
6.2.1 Beijing Minhai Biotechnology Company Information
6.2.2 Beijing Minhai Biotechnology Description and Business Overview
6.2.3 Beijing Minhai Biotechnology Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Beijing Minhai Biotechnology Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Product Portfolio
6.2.5 Beijing Minhai Biotechnology Recent Developments/Updates
6.3 Kangtai
6.3.1 Kangtai Company Information
6.3.2 Kangtai Description and Business Overview
6.3.3 Kangtai Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Kangtai Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Product Portfolio
6.3.5 Kangtai Recent Developments/Updates
6.4 Walvax Biotechnology
6.4.1 Walvax Biotechnology Company Information
6.4.2 Walvax Biotechnology Description and Business Overview
6.4.3 Walvax Biotechnology Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Walvax Biotechnology Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Product Portfolio
6.4.5 Walvax Biotechnology Recent Developments/Updates
6.5 HualanBio
6.5.1 HualanBio Company Information
6.5.2 HualanBio Description and Business Overview
6.5.3 HualanBio Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 HualanBio Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Product Portfolio
6.5.5 HualanBio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Industry Chain Analysis
7.2 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Production Mode & Process Analysis
7.4 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales and Marketing
7.4.1 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Channels
7.4.2 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Distributors
7.5 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Customer Analysis
8 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Dynamics
8.1 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Industry Trends
8.2 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Drivers
8.3 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Challenges
8.4 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi
Beijing Minhai Biotechnology
Kangtai
Walvax Biotechnology
hualanbio
List of Tables
 Table 1. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. Sanofi Company Information
 Table 71. Sanofi Description and Business Overview
 Table 72. Sanofi Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Sanofi Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Product
 Table 74. Sanofi Recent Developments/Updates
 Table 75. Beijing Minhai Biotechnology Company Information
 Table 76. Beijing Minhai Biotechnology Description and Business Overview
 Table 77. Beijing Minhai Biotechnology Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Beijing Minhai Biotechnology Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Product
 Table 79. Beijing Minhai Biotechnology Recent Developments/Updates
 Table 80. Kangtai Company Information
 Table 81. Kangtai Description and Business Overview
 Table 82. Kangtai Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Kangtai Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Product
 Table 84. Kangtai Recent Developments/Updates
 Table 85. Walvax Biotechnology Company Information
 Table 86. Walvax Biotechnology Description and Business Overview
 Table 87. Walvax Biotechnology Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Walvax Biotechnology Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Product
 Table 89. Walvax Biotechnology Recent Developments/Updates
 Table 90. HualanBio Company Information
 Table 91. HualanBio Description and Business Overview
 Table 92. HualanBio Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. HualanBio Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Product
 Table 94. HualanBio Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Distributors List
 Table 98. Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Customers List
 Table 99. Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Trends
 Table 100. Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Drivers
 Table 101. Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Challenges
 Table 102. Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine
 Figure 2. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Share by Type: 2024 & 2031
 Figure 4. 0.5mL Dose Product Picture
 Figure 5. 1.5mL Dose Product Picture
 Figure 6. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. CDC
 Figure 11. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales (2020-2031) & (K Units)
 Figure 14. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 15. Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Report Years Considered
 Figure 16. Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Share by Manufacturers in 2024
 Figure 17. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Players: Market Share by Revenue in Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine in 2024
 Figure 19. Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Market Share by Country (2020-2031)
 Figure 22. North America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Market Share by Country (2020-2031)
 Figure 23. United States Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Market Share by Country (2020-2031)
 Figure 26. Europe Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Market Share by Region (2020-2031)
 Figure 34. China Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine by Type (2020-2031)
 Figure 53. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine by Application (2020-2031)
 Figure 56. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 57. Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Haemophilus Influenzae Type B Vaccine Market Insights Forecast to 2030
Diphtheria Tetanus and Acellular Pertussis Combined Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pertussis Vaccine Market Insights Forecast to 2030
Global Pertussis Vaccination Market Research Report 2025
Global Whooping Cough Preventable Vaccine Market Research Report 2024
Global Pertussis Booster Vaccine Market Research Report 2024
Global Diphtheria Tetanus and Pertussis DTaP Vaccine Market Research Report 2024
Global Haemophilus Influenzae Type B Injection Vaccine Market Research Report 2025
Global DTaP and Tdap Vaccines Market Insights Forecast to 2030
Global Diphtheria Tetanus Pertussis Vaccine Market Research Report 2025
Global Diphtheria Vaccines Market Research Report 2024
Global Haemophilus Influenzae Type b Conjugate Vaccine Market Research Report 2025
Global Combination Vaccines for Children Market Research Report 2024
Global Pentavalent Vaccine Market Research Report 2024
Global Pediatric Preventable Vaccine Market Research Report 2024
Global Combined Polio Vaccine Market Research Report 2024
Global Pertussis Treatment Market Research Report 2024
Global Acellular DTP Vaccine Market Research Report 2024
Haemophilus Influenzae Infection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hepatitis A and B Combined Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions